These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34947815)

  • 1. Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis.
    Shintouo CM; Ghogomu SM; Shey RA; Hotterbeekx A; Yagmur E; Mets T; Vanhamme L; Colebunders R; Souopgui J; Njemini R
    Life (Basel); 2021 Nov; 11(12):. PubMed ID: 34947815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico Design and Validation of OvMANE1, a Chimeric Antigen for Human Onchocerciasis Diagnosis.
    Shintouo CM; Shey RA; Nebangwa DN; K Esoh K; Nongley NF; Nguve JE; Giron P; Mutesa L; Vanhamme L; Souopgui J; Ghogomu SM; Njemini R
    Pathogens; 2020 Jun; 9(6):. PubMed ID: 32580355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Diagnostic Tests for
    Hotterbeekx A; Perneel J; Mandro M; Abhafule G; Siewe Fodjo JN; Dusabimana A; Abrams S; Kumar-Singh S; Colebunders R
    Pathogens; 2020 Jun; 9(6):. PubMed ID: 32498284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of PCR Methods for
    Prince-Guerra JL; Cama VA; Wilson N; Thiele EA; Likwela J; Ndakala N; Muzinga Wa Muzinga J; Ayebazibwe N; Ndjakani YD; Pitchouna NA; Mumba D; Tshefu AK; Ogawa G; Cantey PT
    Am J Trop Med Hyg; 2018 May; 98(5):1427-1434. PubMed ID: 29611501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an OV-16 IgG4 Enzyme-Linked Immunosorbent Assay in Humans and Its Application to Determine the Dynamics of Antibody Responses in a Non-Human Primate Model of
    Cama VA; McDonald C; Arcury-Quandt A; Eberhard M; Jenks MH; Smith J; Feleke SM; Abanyie F; Thomson L; Wiegand RE; Cantey PT
    Am J Trop Med Hyg; 2018 Oct; 99(4):1041-1048. PubMed ID: 30062989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: a case-control study.
    Colebunders R; Mandro M; Mokili JL; Mucinya G; Mambandu G; Pfarr K; Reiter-Owona I; Hoerauf A; Tepage F; Levick B; Begon M; Laudisoit A
    Int J Infect Dis; 2016 Aug; 49():1-8. PubMed ID: 27210267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onchocerca volvulus as a risk factor for developing epilepsy in onchocerciasis endemic regions in the Democratic Republic of Congo: a case control study.
    Mandro M; Suykerbuyk P; Tepage F; Rossy D; Ngave F; Hasan MN; Hotterbeekx A; Mambandu G; Kashama JM; Laudisoit A; Colebunders R
    Infect Dis Poverty; 2018 Oct; 7(1):79. PubMed ID: 30293530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing Reactivity to
    Feeser KR; Cama V; Priest JW; Thiele EA; Wiegand RE; Lakwo T; Feleke SM; Cantey PT
    Am J Trop Med Hyg; 2017 Sep; 97(3):666-672. PubMed ID: 28722605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Multiple Biomarkers to Increase Sensitivity for the Detection of Onchocerca volvulus Infection.
    Bennuru S; Oduro-Boateng G; Osigwe C; Del Valle P; Golden A; Ogawa GM; Cama V; Lustigman S; Nutman TB
    J Infect Dis; 2020 May; 221(11):1805-1815. PubMed ID: 31201416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired antibody responses and loss of reactivity to Onchocerca volvulus antigens by HIV-seropositive onchocerciasis patients.
    Tawill SA; Gallin M; Erttmann KD; Kipp W; Bamuhiiga J; Büttner DW
    Trans R Soc Trop Med Hyg; 1996; 90(1):85-9. PubMed ID: 8730320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes.
    Hernández-González A; Moya L; Perteguer MJ; Herrador Z; Nguema R; Nguema J; Aparicio P; Benito A; Gárate T
    Parasit Vectors; 2016 Sep; 9(1):509. PubMed ID: 27645887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A four-antigen mixture for rapid assessment of Onchocerca volvulus infection.
    Burbelo PD; Leahy HP; Iadarola MJ; Nutman TB
    PLoS Negl Trop Dis; 2009; 3(5):e438. PubMed ID: 19436728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.
    George PJ; Hess JA; Jain S; Patton JB; Zhan T; Tricoche N; Zhan B; Bottazzi ME; Hotez PJ; Abraham D; Lustigman S
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007730. PubMed ID: 31525197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymerase chain reaction-based diagnosis of Onchocerca volvulus infection: improved detection of patients with onchocerciasis.
    Zimmerman PA; Guderian RH; Aruajo E; Elson L; Phadke P; Kubofcik J; Nutman TB
    J Infect Dis; 1994 Mar; 169(3):686-9. PubMed ID: 8158053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo.
    Lenaerts E; Mandro M; Mukendi D; Suykerbuyk P; Dolo H; Wonya'Rossi D; Ngave F; Ensoy-Musoro C; Laudisoit A; Hotterbeekx A; Colebunders R
    Infect Dis Poverty; 2018 Aug; 7(1):68. PubMed ID: 30064504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
    Siewe Fodjo JN; Mandro M; Mukendi D; Tepage F; Menon S; Nakato S; Nyisi F; Abhafule G; Wonya'rossi D; Anyolito A; Lokonda R; Hotterbeekx A; Colebunders R
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007300. PubMed ID: 31314757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
    Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
    Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between clinical disease, circulating antibodies and C1q-binding immune complexes in human onchocerciasis.
    Sisley BM; Mackenzie CD; Steward MW; Williams JF; O'Day J; Luty AJ; Braga M; el Sheikh H
    Parasite Immunol; 1987 Jul; 9(4):447-63. PubMed ID: 3498141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of utilizing the SD BIOLINE Onchocerciasis IgG4 rapid test in onchocerciasis surveillance in Senegal.
    Dieye Y; Storey HL; Barrett KL; Gerth-Guyette E; Di Giorgio L; Golden A; Faulx D; Kalnoky M; Ndiaye MKN; Sy N; Mané M; Faye B; Sarr M; Dioukhane EM; Peck RB; Guinot P; de Los Santos T
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005884. PubMed ID: 28972982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human onchocerciasis and "sowda" in the Republic of Yemen].
    Richard-Lenoble D; al Qubati Y; Toe L; Pisella PJ; Gaxotte P; al Kohlani A
    Bull Acad Natl Med; 2001; 185(8):1447-59; discussion 1459-61. PubMed ID: 11974966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.